The progression of many infections depends on the host’s mechanisms, e.g., the activation of microbial proteins by host proteases such as transmembrane serine protease 2 (TMPRSS2), matriptase, or furin; hence, these enzymes could be relevant pharmacological targets to reduce or even completely stop the infectivity of pathogens. The gene discussed is TMPRSS2; the disease is infection.